BI Asset Management Fondsmaeglerselskab’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,768
Closed -$977K 464
2020
Q1
$977K Buy
+6,768
New +$977K 0.06% 249